Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bipolar Disorder | 4 | 1994 | 307 | 0.270 |
Why?
|
Antidepressive Agents, Second-Generation | 3 | 2000 | 54 | 0.210 |
Why?
|
Lithium | 2 | 1993 | 76 | 0.170 |
Why?
|
Fluvoxamine | 6 | 1999 | 22 | 0.140 |
Why?
|
Psychiatric Department, Hospital | 1 | 1995 | 17 | 0.130 |
Why?
|
Cyclohexanols | 1 | 1995 | 12 | 0.130 |
Why?
|
Pharmacy Service, Hospital | 1 | 1995 | 52 | 0.130 |
Why?
|
Psychotropic Drugs | 1 | 1995 | 83 | 0.120 |
Why?
|
Depressive Disorder | 5 | 1994 | 621 | 0.120 |
Why?
|
Alcohol Withdrawal Delirium | 1 | 1994 | 24 | 0.120 |
Why?
|
Phobic Disorders | 3 | 2000 | 227 | 0.110 |
Why?
|
Referral and Consultation | 1 | 1995 | 383 | 0.110 |
Why?
|
Imipramine | 4 | 1994 | 44 | 0.110 |
Why?
|
Seizures | 1 | 1994 | 279 | 0.100 |
Why?
|
Substance-Related Disorders | 2 | 1994 | 1242 | 0.100 |
Why?
|
Clonazepam | 1 | 1989 | 6 | 0.090 |
Why?
|
Lorazepam | 1 | 1989 | 54 | 0.080 |
Why?
|
Alcoholism | 2 | 1994 | 1109 | 0.070 |
Why?
|
Salicylates | 1 | 1986 | 22 | 0.070 |
Why?
|
Delirium | 1 | 1986 | 45 | 0.070 |
Why?
|
Drug Interactions | 2 | 1995 | 289 | 0.060 |
Why?
|
Double-Blind Method | 6 | 1995 | 1738 | 0.050 |
Why?
|
Clinical Trials as Topic | 4 | 1995 | 848 | 0.050 |
Why?
|
Adult | 12 | 2000 | 21403 | 0.040 |
Why?
|
Humans | 18 | 2000 | 68618 | 0.040 |
Why?
|
Bupropion | 1 | 2000 | 63 | 0.040 |
Why?
|
Antidepressive Agents | 2 | 1994 | 216 | 0.040 |
Why?
|
Male | 13 | 2000 | 37321 | 0.040 |
Why?
|
Receptors, GABA-A | 1 | 1998 | 89 | 0.040 |
Why?
|
Middle Aged | 10 | 1999 | 21147 | 0.040 |
Why?
|
Female | 12 | 2000 | 38074 | 0.030 |
Why?
|
Hospital Bed Capacity, 500 and over | 1 | 1995 | 14 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 1995 | 219 | 0.030 |
Why?
|
Absorption | 1 | 1995 | 49 | 0.030 |
Why?
|
Hospitals, Teaching | 1 | 1995 | 65 | 0.030 |
Why?
|
Venlafaxine Hydrochloride | 1 | 1995 | 42 | 0.030 |
Why?
|
Irritable Mood | 1 | 1994 | 15 | 0.030 |
Why?
|
Thyroid Gland | 1 | 1994 | 67 | 0.030 |
Why?
|
Clomipramine | 1 | 1994 | 8 | 0.030 |
Why?
|
Marital Status | 1 | 1994 | 65 | 0.030 |
Why?
|
Age of Onset | 1 | 1994 | 188 | 0.030 |
Why?
|
Interprofessional Relations | 1 | 1995 | 188 | 0.030 |
Why?
|
Inpatients | 1 | 1995 | 208 | 0.030 |
Why?
|
Neurologic Examination | 1 | 1994 | 107 | 0.030 |
Why?
|
Substance Abuse Treatment Centers | 1 | 1994 | 71 | 0.030 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 1994 | 88 | 0.030 |
Why?
|
Educational Status | 1 | 1994 | 273 | 0.030 |
Why?
|
Receptors, Cholinergic | 1 | 1993 | 30 | 0.030 |
Why?
|
Catecholamines | 1 | 1993 | 73 | 0.030 |
Why?
|
Desipramine | 1 | 1993 | 47 | 0.030 |
Why?
|
Cardiovascular System | 1 | 1993 | 85 | 0.030 |
Why?
|
Panic Disorder | 1 | 1993 | 121 | 0.030 |
Why?
|
Drug Monitoring | 1 | 1993 | 107 | 0.030 |
Why?
|
Retrospective Studies | 2 | 1995 | 7277 | 0.030 |
Why?
|
Ambulatory Care | 1 | 1994 | 340 | 0.020 |
Why?
|
Electroencephalography | 1 | 1994 | 418 | 0.020 |
Why?
|
Sex Factors | 1 | 1994 | 1266 | 0.020 |
Why?
|
Comorbidity | 1 | 1994 | 1426 | 0.020 |
Why?
|
Aged | 6 | 1995 | 14862 | 0.020 |
Why?
|
Oximes | 1 | 1989 | 10 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1993 | 1745 | 0.020 |
Why?
|
South Carolina | 1 | 1995 | 2752 | 0.020 |
Why?
|
Hospitalization | 1 | 1994 | 978 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 1989 | 567 | 0.020 |
Why?
|
Ethanol | 1 | 1994 | 893 | 0.020 |
Why?
|
Rats | 1 | 1995 | 5300 | 0.020 |
Why?
|
Heart Rate | 2 | 1999 | 568 | 0.020 |
Why?
|
Blood Pressure | 3 | 1999 | 1451 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 1988 | 498 | 0.010 |
Why?
|
Risk Factors | 1 | 1994 | 5731 | 0.010 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 1994 | 1506 | 0.010 |
Why?
|
Delayed-Action Preparations | 1 | 2000 | 120 | 0.010 |
Why?
|
Single-Blind Method | 1 | 1999 | 249 | 0.010 |
Why?
|
Hypertension | 1 | 1988 | 1535 | 0.010 |
Why?
|
Peripheral Nervous System | 1 | 1998 | 12 | 0.010 |
Why?
|
Isoquinolines | 1 | 1998 | 37 | 0.010 |
Why?
|
Hydrocortisone | 1 | 1999 | 291 | 0.010 |
Why?
|
Animals | 1 | 1995 | 20881 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1999 | 782 | 0.010 |
Why?
|
Blood Platelets | 1 | 1998 | 284 | 0.010 |
Why?
|
Thyroid Hormones | 1 | 1994 | 31 | 0.010 |
Why?
|
Trazodone | 1 | 1994 | 5 | 0.010 |
Why?
|
1-Naphthylamine | 1 | 1994 | 11 | 0.010 |
Why?
|
Fluoxetine | 1 | 1994 | 40 | 0.010 |
Why?
|
Sertraline | 1 | 1994 | 62 | 0.010 |
Why?
|
Serotonin | 1 | 1994 | 144 | 0.010 |
Why?
|
Hypotension, Orthostatic | 1 | 1993 | 15 | 0.010 |
Why?
|
Pulse | 1 | 1993 | 23 | 0.010 |
Why?
|
Normetanephrine | 1 | 1993 | 8 | 0.010 |
Why?
|
Vanilmandelic Acid | 1 | 1993 | 6 | 0.010 |
Why?
|
Metanephrine | 1 | 1993 | 11 | 0.010 |
Why?
|
Methoxyhydroxyphenylglycol | 1 | 1993 | 41 | 0.010 |
Why?
|
Receptors, Adrenergic | 1 | 1993 | 68 | 0.010 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 1993 | 40 | 0.010 |
Why?
|
Placebos | 1 | 1993 | 195 | 0.010 |
Why?
|
Norepinephrine | 1 | 1993 | 276 | 0.010 |
Why?
|
Synaptic Transmission | 1 | 1994 | 236 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1994 | 1040 | 0.010 |
Why?
|
Dopamine | 1 | 1994 | 474 | 0.010 |
Why?
|
Anxiety Disorders | 1 | 1994 | 426 | 0.010 |
Why?
|
Electrocardiography | 1 | 1993 | 601 | 0.010 |
Why?
|
Adolescent | 2 | 1993 | 8912 | 0.010 |
Why?
|
Outpatients | 1 | 1989 | 127 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2000 | 7029 | 0.000 |
Why?
|
Random Allocation | 1 | 1989 | 442 | 0.000 |
Why?
|
Depression | 1 | 1994 | 943 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 1989 | 4848 | 0.000 |
Why?
|